Matteo Trucco MD
Pediatric Hematologic Oncology, Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology
Associate Professor of Pediatrics Cleveland Clinic Lerner College of Medicine Case Western Reserve University Cleveland Clinic Children’s Director Children’s Cancer Innovative Therapy Program
Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-444-2200
Dr. Trucco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Matteo Trucco is a pediatric hematologist/oncologist at the Cleveland Clinic in Cleveland, OH specializing in pediatric sarcomas and the development on new treatments for childhood cancers. He received his medical degree from Temple University School of Medicine and has been in practice 11 years. He also speaks multiple languages, including Spanish and Italian. He is involved in several organization whose mission is to improve the outcomes for children battling cancer including the National Pediatric Cancer Foundation, MIB Agents and the SebastianStrong Foundation.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2009 - 2012
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 2006 - 2009
Lewis Katz School of Medicine at Temple UniversityClass of 2006
University of PennsylvaniaBA, Biology, Philosophy of Science, 1997 - 2001
Certifications & Licensure
OH State Medical License 2006 - 2025
FL State Medical License 2016 - 2020
TX State Medical License 2012 - 2017
MD State Medical License 2009 - 2013
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Start of enrollment: 2012 Aug 01
- Dendritic Cell Vaccine for Children and Adults With Sarcoma Start of enrollment: 2014 Jan 06
- Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas Start of enrollment: 2016 Apr 19
- Join now to see all
Publications & Presentations
PubMed
- Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Fou...Aditi Dhir, Masanori Hayashi, Avery Bodlak, Javier Oesterheld, David M Loeb
Clinical Cancer Research. 2024-12-02 - Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board.Ajay Gupta, Matthew S Dietz, Richard F Riedel, Aditi Dhir, Scott C Borinstein
Cancer. 2024-12-01 - Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of "Fusion-Positive" Cases.Josephine K Dermawan, Faizan Malik, John M Gross, Ezra Baraban, Christine Pratilas
Modern Pathology. 2024-11-01
Press Mentions
First Two Programs Accredited Under New ACS Commission on Cancer Pediatric DesignationMarch 25th, 2025- Cleveland Clinic Hosts 2nd Annual Virtual Head-Shaving Event for Childhood Cancer ResearchMay 16th, 2021
SebastianStrong Awards $225,000 Discovery Science Grant for Childhood Brain Cancer ResearchAugust 7th, 2020- Join now to see all
Other Languages
- Spanish, Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
